The lab led by Dr. Jefferson Matthew Taliaferro focuses on understanding how RNA localization impacts neuron function and its misregulation in diseases like ALS. By investigating the RNA-binding protein TDP-43, which is crucial for transporting RNA within neurons, the lab aims to uncover the consequences of RNA mislocalization in neurological disorders. The research combines advanced techniques in live cell imaging and stem cell biology to explore fundamental cellular processes that have implications for developing new therapeutic strategies.

Dr. Yue Wang's research lab at the University of Colorado Denver focuses on improving the analysis of gene pathways to better understand complex human diseases. They are developing advanced statistical models that can accurately capture the interactions between genes and their effects on health, particularly using data from RNA sequencing. Their innovative approaches aim to reduce inaccuracies in current pathway analysis methods, paving the way for groundbreaking insights into disease mechanisms.

Dr. Chad G. Pearson's lab explores how centrioles and centrosomes function as crucial controllers of cellular organization, particularly their roles in cell division and cilia formation. Their research focuses on understanding how disruptions in these structures can lead to diseases like cancer and Down syndrome. This work has broad implications for our understanding of cell behavior and potential therapeutic strategies.

Dr. Matthew J. Sikora's lab focuses on understanding the biology behind certain types of cancers, specifically gynecologic cancers like ovarian cancer and specific breast cancer subtypes such as invasive lobular carcinoma. The lab investigates how genetic variations and molecular factors drive tumor growth, therapy resistance, and health disparities among different populations. Their research aims to reveal the underlying mechanisms of cancer progression and treatment responses, potentially leading to more effective therapies tailored to patient genetics.

Dr. Rui Zhao's research lab focuses on understanding the complex process of pre-mRNA splicing, which is crucial for gene expression in eukaryotes. By studying the spliceosome, a large RNA/protein complex, the lab aims to uncover how errors in splicing can lead to genetic disorders and other diseases. Research in this lab combines structural, biochemical, and genetic approaches to fill knowledge gaps regarding splicing mechanisms and their implications for human health.

Dr. Matthew J. Kennedy's lab at the University of Colorado Denver focuses on understanding how the tiny structures within synapses, which are connections between neurons, influence brain function. They are developing innovative tools to manipulate these structures in real time, which will help reveal their role in important cognitive processes, such as learning and memory. This research aims to bridge the gap between the molecular dynamics of synapses and their impact on cognitive functions, potentially shedding light on brain disorders linked to synaptic dysfunction.

Dr. Mark L Dell'Acqua's lab at the University of Colorado Denver focuses on understanding how amyloid beta, a protein involved in Alzheimer's disease, disrupts synaptic function in the brain. The lab investigates the molecular signaling pathways that control synaptic plasticity—the brain's ability to adapt and change. By studying these pathways, the research aims to identify potential therapeutic targets that could help preserve cognitive function in individuals affected by Alzheimer's disease.

Dr. Anthony Wei Peng's lab at the University of Colorado Denver focuses on the intricate processes that enable our ears to hear. By studying how hair cells in the cochlea convert sound vibrations into electrical signals, the lab aims to understand the molecular mechanisms behind hearing and the effects of genetic mutations that could lead to hearing loss. Their research not only sheds light on normal auditory function but also seeks to identify potential targets for improving therapies for hearing impairments.